50
Participants
Start Date
October 3, 2024
Primary Completion Date
November 4, 2027
Study Completion Date
November 4, 2027
Durvalumab
Chemo-radiotherapy + Durvalumab for non-resectable stage III NSCLC patients according to clinical practice of each participant hospital
NOT_YET_RECRUITING
Hospital General Universitario de Ciudad Real, Ciudad Real
RECRUITING
Hospitalario Universitario A Coruña, A Coruña
NOT_YET_RECRUITING
Complejo Hospitalario Universitario Del Ferrol, Ferrol
RECRUITING
ICO Girona, Hospital Josep Trueta, Girona
RECRUITING
Hospital Universitario Lucus Augusti, Lugo
NOT_YET_RECRUITING
Hospital Universitario De La Princesa, Madrid
NOT_YET_RECRUITING
Hospital Clínico San Carlos, Madrid
NOT_YET_RECRUITING
Hospital Universitario Fundación Jiménez Díaz, Madrid
NOT_YET_RECRUITING
Hospital Universitario La Paz, Madrid
NOT_YET_RECRUITING
Hospital Universitario Puerta de Hierro, Majadahonda
NOT_YET_RECRUITING
Hospital Universitario Central De Asturias, Oviedo
RECRUITING
Hospital Universitari de Gran Canària Doctor Negrín, Las Palmas de Gran Canaria
RECRUITING
Complexo Hospitalario Universitario De Vigo, Vigo
NOT_YET_RECRUITING
Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife
NOT_YET_RECRUITING
Hospital Virgen del Rocio, Seville
RECRUITING
Hospital Universitario Y Politécnico La Fe, Valencia
NOT_YET_RECRUITING
Hospital Clínico Universitario de Valladolid, Valladolid
RECRUITING
Hospital De Basurto, Bilbao
NOT_YET_RECRUITING
ICO Badalona, Hospital Germans Trias i Pujol, Badalona
RECRUITING
Hospital General Universitario de Alicante, Alicante
NOT_YET_RECRUITING
Hospital Universitari Vall d' Hebron, Barcelona
RECRUITING
Hospital de la Santa Creu i Sant Pau, Barcelona
Fundación GECP
OTHER